⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4556705 | 0.91 | — | — | |
| SCHEMBL3075733 | 0.88 | — | — | |
| SCHEMBL4518990 | 0.80 | — | — | |
| SCHEMBL2036809 | 0.76 | TSHR (0.38) | — | |
| SCHEMBL1518055 | 0.75 | TSHR (0.46) | — | |
| SCHEMBL30955 | 0.73 | — | — | |
| 1,4-Butanediol SCHEMBL1538425 | 0.72 | SMN1; SMN2 (0.41) | — | |
| SCHEMBL4557216 | 0.71 | — | — | |
| SCHEMBL17937800 | 0.71 | — | — | |
| SCHEMBL1988339 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 151 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111233679-B | Quaternary ammonium salt containing hydroxypropyl alkyl and synthetic method thereof | 中国日用化学研究院有限公司 | 2023-01-03 | — | — | CN | claimed |
| WO-2021118915-A1 | HYDROXYPROPYL ALKYL CELLULOSE ACETATE SUCCINATE HETEROPOLYMERS | NUTRITION & BIOSCIENCES USA 1, LLC (US) | 2021-06-17 | — | — | WO | claimed |
| CN-112566625-A | Oral dosage chemotherapeutic drug suspensions | 夫特弗制药私人有限公司 | 2021-03-26 | — | — | CN | claimed |
| EP-3677254-A1 | SOLID ORAL PHARMACEUTICAL COMPOSITIONS OF DESVENLAFAXINE | Sanovel Ilac Sanayi ve Ticaret A.S. (TR) | 2020-07-08 | — | — | EP | claimed |
| CN-111233679-A | Quaternary ammonium salt containing hydroxypropyl alkyl and synthetic method thereof | 中国日用化学研究院有限公司 | 2020-06-05 | — | — | CN | claimed |
| US-20160317454-A1 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION AND METHOD FOR MANUFACTURING THE SAME | MEDICAL AND PHARMACEUTICAL INDUSTRY TECHNOLOGY AND DEVELOPMENT CENTER (TW) | 2016-11-03 | — | — | US | claimed |
| EP-2007378-B1 | PHARMACEUTICAL COMPOSITION COMPRISING LIPASE INHIBITOR AND LIPOPHILIC OIL ABSORBENT AND ORAL FORMULATION PREPARED THEREFROM | AMOREPACIFIC CORP (KR) | 2016-03-30 | — | — | EP | claimed |
| US-8246985-B2 | Pharmaceutical composition comprising lipase inhibitor and lipophilic oil absorbent and oral formulation prepared therefrom | AMOREPACIFIC CORPORATION (KR) | 2012-08-21 | — | — | US | claimed |
| US-20090068277-A1 | PHARMACEUTICAL COMPOSITION COMPRISING LIPASE INHIBITOR AND LIPOPHILIC OIL ABSORBENT AND ORAL FORMULATION PREPARED THEREFROM | AMOREPACIFIC CORPORATION (KR) | 2009-03-12 | — | — | US | claimed |
| EP-2007378-A1 | PHARMACEUTICAL COMPOSITION COMPRISING LIPASE INHIBITOR AND LIPOPHILIC OIL ABSORBENT AND ORAL FORMULATION PREPARED THEREFROM | Amorepacific Corporation (KR) | 2008-12-31 | — | — | EP | claimed |
| US-20080131511-A1 | Pharmaceutical Composition for Treatment of Tear and Salivary Fluid Drying | ASTELLAS PHARMA, INC. | 2008-06-05 | — | — | US | claimed |
| WO-2007123338-A1 | PHARMACEUTICAL COMPOSITION COMPRISING LIPASE INHIBITOR AND LIPOPHILIC OIL ABSORBENT AND ORAL FORMULATION PREPARED THEREFROM | AMOREPACIFIC CORPORATION (KR) | 2007-11-01 | — | — | WO | claimed |
| WO-2007069827-A1 | PHARMACEUTICAL COMPOSITION WITH EXTENDED RELEASE LAYER AND FAST RELEASE LAYER FOR TREATMENT OF HYPERLIPIDEMIA AND ARTERIOSCLEROSIS | CHONG KUN DANG PHARMACEUTICAL CORP. (KR) | 2007-06-21 | — | — | WO | claimed |
| US-6123753-A | Aqueous dispersions of hydrophobizing agents | CRAIG DANIEL H (US) | 2000-09-26 | — | — | US | claimed |
| US-5370878-A | Dry milling a compacted blend of acetaminophen, binder, lubricant, disintegrating agent and water or alkalnol followee by tableting | HALLMARK PHARMACEUTICALS, INC. (US) | 1994-12-06 | — | — | US | claimed |
| JP-4369815-A | — | — | None | — | — | JP | disclosed |
| JP-4369814-A | — | — | None | — | — | JP | disclosed |
| JP-H04369816-A | ELECTROLYTE FOR ELECTROLYTIC CAPACITOR | NIPPON CHEMICON CORP | 1992-12-22 | — | — | JP | disclosed |
| JP-H04369815-A | ELECTROLYTE FOR ELECTROLYTIC CAPACITOR | NIPPON CHEMICON CORP | 1992-12-22 | — | — | JP | disclosed |
| CN-1033046-A | Be used for the treatment of and prevent the pentamidine salts of pneumocystis carinii pneumonia | LYPHOMED LTD (US) | 1989-05-24 | — | — | CN | disclosed |